Cargando…

Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature

BACKGROUND: Cannabis intoxication is related to a number of physical and mental health risks with ensuing social costs. However, little attention has been given to the investigation of possible pharmacological interactions in this condition. OBJECTIVE: To review the available scientific literature c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crippa, José AS, Derenusson, Guilherme N, Chagas, Marcos HN, Atakan, Zerrin, Martín-Santos, Rocio, Zuardi, Antonio W, Hallak, Jaime EC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294246/ https://www.ncbi.nlm.nih.gov/pubmed/22273390 http://dx.doi.org/10.1186/1477-7517-9-7

Ejemplares similares

Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930–March 9, 2023) and his legacy for Brazilian pharmacology
por: Crippa, José Alexandre S., et al.
Publicado: (2023)

Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
por: Crippa, José A. S., et al.
Publicado: (2016)

Marijuana, feijoada and the debate on drug legalization
por: Crippa, José A. S., et al.
Publicado: (2013)

The first department of medical psychology in the world and its impact on medical education
por: Crippa, José A.S., et al.
Publicado: (2021)

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
por: Linares, Ila M. P., et al.
Publicado: (2018)

The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
por: Bolsoni, Lívia Maria, et al.
Publicado: (2022)

F198. EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
por: Almeida, Valéria, et al.
Publicado: (2018)

Increased body sway in phobic patients exposed to images of spiders
por: Linares, Ila M.P., et al.
Publicado: (2020)

Is it the Ideal Time to Start Prescribing Cannabis Derivatives to Treat Endometriosis-associated Pain?
por: Poli-Neto, Omero Benedicto, et al.
Publicado: (2022)

Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
por: Peres, Fernanda F., et al.
Publicado: (2016)

Pharmacological interventions during the process of reconsolidation of aversive memories: A systematic review
por: Bolsoni, Lívia Maria, et al.
Publicado: (2019)

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
por: Vuolo, Francieli, et al.
Publicado: (2015)

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
por: Zuardi, Antonio W., et al.
Publicado: (2017)

Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies
por: dos Santos, Rafael G., et al.
Publicado: (2016)

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
por: Levin, Raquel, et al.
Publicado: (2014)

Monitoring the Mental Health and Professional Overload of Health Workers in Brazil: A Longitudinal Study Considering the First Wave of the COVID-19 Pandemic
por: Osório, Flávia L., et al.
Publicado: (2022)

Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study
por: Loureiro, Sonia Regina, et al.
Publicado: (2023)

Systemic Chronic Treatment with Cannabidiol in Carioca High- and Low-Conditioned Freezing Rats in the Neuropathic Pain Model: Evaluation of Pain Sensitivity
por: Macêdo-Souza, Carolina, et al.
Publicado: (2023)

Psychosocial and pharmacological interventions for the treatment of cannabis use disorder
por: Sabioni, Pamela, et al.
Publicado: (2018)

Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
por: de Meneses-Gaya, Carolina, et al.
Publicado: (2020)

Workplace Protections and Burnout Among Brazilian Frontline Health Care Professionals During the COVID-19 Pandemic
por: Pereira-Lima, Karina, et al.
Publicado: (2022)

Harmine and Imipramine Promote Antioxidant Activities in Prefrontal Cortex and Hippocampus
por: Réus, Gislaine Z., et al.
Publicado: (2010)

Risk and Protective Factors for the Mental Health of Brazilian Healthcare Workers in the Frontline of COVID-19 Pandemic
por: Osório, Flávia L., et al.
Publicado: (2021)

Evaluation of the role of the cannabidiol system in an animal model of ischemia/reperfusion kidney injury
por: Soares, Rodrigo Zon, et al.
Publicado: (2015)

Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload
por: da Silva, Vanessa Kappel, et al.
Publicado: (2018)

Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021)
por: de Lima Osório, Flávia, et al.
Publicado: (2023)

Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)
por: Souza, José Diogo R., et al.
Publicado: (2022)

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
por: Loss, Cássio Morais, et al.
Publicado: (2021)

Biological bases for a possible effect of cannabidiol in Parkinson’s disease
por: Ferreira-Junior, Nilson C., et al.
Publicado: (2019)

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
por: Peres, Fernanda F., et al.
Publicado: (2018)

Synthetic Cannabis-Induced Mania
por: Ustundag, Mehmet Fatih, et al.
Publicado: (2015)

17.4 POSSIBLE MECHANISMS INVOLVED IN THE ANTIPSYCHOTIC EFFECTS OF CANNABIDIOL (CBD)
por: Crippa, Jose Alexandre, et al.
Publicado: (2018)

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans
por: Nahler, Gerhard, et al.
Publicado: (2017)

Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature
por: Rocha, Juliana M., et al.
Publicado: (2019)

Why should Cannabis be Considered Doping in Sports?
por: Bergamaschi, Mateus M., et al.
Publicado: (2013)

Pharmacological interventions for improving cannabis use and psychosis in dual diagnosis: a systematic review
por: Bharj, Arundeep Singh, et al.
Publicado: (2021)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
por: Crippa, José A., et al.
Publicado: (2018)

Even High Doses of Oral Cannabidiol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102–112; DOI: 10.1089/can.2015.0004
por: Grotenhermen, Franjo, et al.
Publicado: (2017)

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
por: Montoya, Zackary, et al.
Publicado: (2020)

Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
por: Falvella, Ana Caroline Brambilla, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_22va1rens7i5p7rc4qo8e1v9l2